Entering text into the input field will update the search result below

Insulet to pay $20M to Roche in patent settlement

Jul. 11, 2022 11:25 AM ETInsulet Corporation (PODD) StockRHHBY, RHHBFBy: Dulan Lokuwithana, SA News Editor1 Comment

Patents files folder

oonal/iStock via Getty Images

  • Insulet Corporation (NASDAQ:PODD), a maker of insulin delivery systems, announced an agreement with Swiss pharma giant Roche (OTCQX:RHHBY) (OTCQX:RHHBF) on Monday to settle a patent infringement lawsuit brought against the company.
  • Announcing the terms of

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

"In return, Roche has agreed not to sue the company for five years."

So, just kicking the can down the road.

About PODD

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Insulet Corporation
Smith & Nephew plc
Teleflex Incorporated
Hologic, Inc.
Olympus Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.